Rightmark vs Protege: data licensing and buyer fit

Rightmark's owner offer Rightmark, 7 Oct 2026 (opens in a new tab) and buyer process Rightmark, 21 Oct 2026 (opens in a new tab) set out those starting points.

Protege has a distinct case when your purchase includes specialist evaluation. It announced independent healthcare model testing on October 21, 2026. A dataset license and a service that tests your model are different deliverables. Decide which you need before comparing proposals. Protege's evaluation announcement Protege, 21 Oct 2026 (opens in a new tab)

Bring the decision down to a defined scope. Owners can appraise their data. AI teams can request data Rightmark, 21 Oct 2026 (opens in a new tab) with the intended use, required content and evidence they need to assess it.

Rightmark publishes this comparison. Updated October 22, 2026. Provider descriptions come from their public pages; they are not audited transaction results or independently verified performance claims.

Use the owner rows to compare licensing proposals and the buyer rows to compare what your team will receive. These are selection criteria, not a provider rating.

The Rightmark homepage Rightmark, 7 Oct 2026 (opens in a new tab), buyer page Rightmark, 21 Oct 2026 (opens in a new tab), Protege owner program Protege, 28 Feb 2026 (opens in a new tab), buyer program Protege, 27 Feb 2026 (opens in a new tab) and evaluation announcement Protege, 21 Oct 2026 (opens in a new tab) support the summaries. The sections below explain the limits that matter.

The useful number is what becomes payable to you for a specified set of rights. A percentage alone cannot establish whether an offer is attractive: the underlying price, covered assets and obligations may differ.

Rightmark publishes no upfront fee. On standard licenses, it takes nothing from the owner's payout and charges its fee to the buyer on top. On premium and bespoke deals, the owner keeps 75% to 85%, agreed in writing. That distinction gives owners a concrete starting point for understanding the economics. It does not establish the highest payout for every asset. Rightmark's published fee model Rightmark, 7 Oct 2026 (opens in a new tab)

Protege describes a revenue-share agreement on its other-domains owner page; it does not publish a percentage there. Request the actual proposal before making a payout comparison. Protege's owner process Protege, 28 Feb 2026 (opens in a new tab)

Put the same information against both proposals:

A standard Rightmark offer is especially worth evaluating when owner-payout clarity matters. Still ask for the actual amounts and conditions. A buyer-paid fee preserves the stated owner payout; it does not mean the owner receives all buyer spending, or that the buyer pays less overall.

Ask both: “For this exact scope and use, what amount is payable to us, which deductions can change it, and what event makes payment due?” If one proposal prices different rights, resolve that difference before comparing the money.

Retaining ownership is valuable, but it does not answer every question about control. A license can leave ownership intact while granting uses that matter commercially to the owner.

Protege says partners retain ownership and license defined AI purposes, with no public exhibition or redistribution. That is the stated program boundary; the actual agreement still needs review. Protege's owner FAQ Protege, 28 Feb 2026 (opens in a new tab)

Rightmark explains its routes separately. Code is non-exclusive by default, and signing can authorize later non-exclusive licenses without a new approval for every transaction. Code that has not been licensed can be withdrawn; licenses already granted survive. Company-archive lump-sum routes generally involve different exclusivity terms. Rightmark's licensing guide Rightmark, 18 Oct 2026 (opens in a new tab) and Trust page Rightmark, 18 Oct 2026 (opens in a new tab)

There are material limits to read before proceeding. Some code arrangements permit sublicensing or derived datasets; other own-product or retained-derived rights depend on the license. Some ownership indemnities can be uncapped. Those are reasons to establish the scope and ownership evidence carefully, particularly for client work or assets with uncertain contributor rights. They should not disappear behind a general promise that you keep your IP. Route-specific rights and responsibilities Rightmark, 18 Oct 2026 (opens in a new tab)

Rightmark's advantage for this decision is the ability to start from published route distinctions and press for a matching agreement. The right choice is a grant you understand and can authorize. Neither provider's ownership statement substitutes for that work.

Ask both: “Which future uses need a new approval, what rights survive withdrawal, and what exposure do we retain for an ownership dispute?” These are contract-review questions, not legal advice.

Preparation can include very different jobs: describing an asset, detecting obvious risks, removing excluded content, preserving relationships between records and constructing a usable delivery. Ask which jobs are included and what evidence each produces.

Protege lists curation, quality control, masking and dataset construction. That is a useful preparation proposition to examine with a scoped work plan. Protege's preparation process Protege, 28 Feb 2026 (opens in a new tab)

Rightmark starts owner appraisal with answers, without files or access. For code, Repo Check Rightmark, 21 Oct 2026 (opens in a new tab) runs locally, makes no network connections and runs none of the repository's code. The owner can review the shareable report before sending it. This is a practical way to begin an assessment without treating a raw repository transfer as the first step. Rightmark's assessment boundary Rightmark, 18 Oct 2026 (opens in a new tab)

Keep the meaning of the report precise. Repo Check can read counts from an existing JUnit test report; it does not execute the tests. A count of passing tests is different from independently reproducing that result. A readiness report also does not establish legal title, settle every privacy question or prove that a buyer's model will benefit.

Rightmark fits owners who want that first assessment boundary made explicit, particularly for code. A provider offering more preparation work may be useful when you need packaging support; compare its actual responsibilities and evidence, not the phrase “AI-ready.”

Ask both: “What do you need before the agreement, who performs each preparation step, and which checks will still be outstanding afterward?”

A label such as company records or agentic data is not a specification. Your team may need complete sequences, linked context, particular source systems or a defined history. A collection that matches the category can still miss the task.

Protege's other-domains buyer page includes agentic work traces, AEC records and financial data examples. It describes constructing datasets for a specific training purpose. Protege's buyer offering Protege, 27 Feb 2026 (opens in a new tab)

Rightmark's buyer process starts with a written scope, then an ownership pack for the route, representative scrubbed samples under NDA and agreed delivery. It is a strong option when your team wants sourcing organized around a concrete requirement and the evidence behind it. Rightmark for AI buyers Rightmark, 21 Oct 2026 (opens in a new tab)

Separate a published sourcing direction from confirmed supply. The pooled collections labeled “in preparation” on Rightmark's buyer page are not available yet. That statement applies to those planned collections, not every separately described lot. Ask what is available for your request, what still needs sourcing and what can be sampled now.

A useful sample must support the test you intend to run. If your task depends on relationships across records, an isolated export may be insufficient even if every individual file opens correctly. Conversely, do not request a broad archive when a narrow approved sample answers the question.

Rightmark's sample-pack guide Rightmark, 18 Oct 2026 (opens in a new tab) makes an important boundary explicit: a sample helps assess fit but does not guarantee full-collection quality or acceptance. Put the mismatch process in the proposal instead of assuming a refund or replacement policy.

Ask both: “Which records, relationships and permissions satisfy this task, and which requested elements are still to be sourced?” Then confirm that the quoted version matches the one your team evaluated.

This is a different purchasing decision. An evaluation dataset gives your team material to test against. A test-execution engagement also needs an evaluator, a method and a defined output. The price and rights should match the deliverable.

Protege's current healthcare evaluation page describes private held-out testing and a score, report and attestation. Its October 21 announcement says it independently designs, runs and scores evaluations. Healthcare evaluation service Protege, 24 Sep 2026 (opens in a new tab), launch announcement Protege, 21 Oct 2026 (opens in a new tab)

In that announcement, Engy Ziedan, Protege's co-founder and Chief Scientific Officer, calls for “questions that reflect real clinical workflows.” This is the supplier's stated evaluation principle. It suggests a useful procurement question: does the proposed work test the workflow you actually care about, or simply produce a score on a convenient task? Ziedan's statement Protege, 21 Oct 2026 (opens in a new tab)

These columns are purchasing questions, not promises about every contract. For example, receiving a test report does not by itself establish a right to train on the test set.

Protege is the more relevant option for the healthcare evaluation service it documents. Rightmark's published buyer route is dataset sourcing and licensing, and it does not currently take health data. Do not choose a general sourcing path as a substitute for that specialist requirement. Rightmark's current eligibility Rightmark, 7 Oct 2026 (opens in a new tab)

Ask both: “Are we buying licensed data, test execution or both, and which access and reuse rights attach to each output?” This comparison does not assess clinical efficacy or whether a model is ready for deployment.

Copy this blank table into your procurement document. Keep private evidence references in your own controlled workspace; do not paste credentials, raw records or confidential contracts into a public copy.

Consider a fictional example: a buyer requests a workflow evaluation and receives an archive sample without scoring rules. The sample might be useful, but the proposal has not established whether test execution is included. The next action is to resolve the deliverable, not select the cheaper headline.

For owners, the equivalent gap is a retained-ownership statement without an answer about future approvals. Mark the missing agreement term rather than treating the general statement as a complete answer.

Choose Protege for the documented healthcare evaluation requirement when the scope and method meet your needs. Its preparation work can also suit owners needing packaging support, while its domain-specific sourcing warrants evaluation for buyers with a matching requirement. Evaluation Protege, 24 Sep 2026 (opens in a new tab), owner preparation Protege, 28 Feb 2026 (opens in a new tab), buyer sourcing Protege, 27 Feb 2026 (opens in a new tab)

Request the current proposal for the actual asset or workflow. A favorable category match does not settle rights, availability, acceptance or price.

Choose Rightmark when you want a supported data-licensing opportunity evaluated with a clear starting fee model, an explicit assessment boundary and route-specific rights. For code owners, local Repo Check adds a useful preparation step before broader access. The value is that you can understand the proposal and its unresolved evidence before committing.

For AI buyers, choose Rightmark when your job is to source a defined licensed dataset and you want ownership evidence, a permitted sample and delivery requirements connected to that request. Keep owner proceeds and your full acquisition quote separate. Favorable owner economics alone do not establish the lowest buyer price. Rightmark's buyer path Rightmark, 21 Oct 2026 (opens in a new tab)

If essential ownership, sample permission or the intended output remains undefined, pause the purchase and resolve it. A provider selection cannot supply a missing permission.

Get a proposal you can evaluate. Appraise your data as an owner, or send Rightmark your dataset requirement Rightmark, 21 Oct 2026 (opens in a new tab) as an AI buyer. Bring the same scope and unanswered questions to each provider you shortlist.